target

Shire

bidder

Takeda Pharmaceutical Company

£44,351m

154 dealmakers

target

Consumer Health Joint Venture

bidder

Pfizer

£9,800m

78 dealmakers

target

Celgene Corporation

bidder

Bristol Myers Squibb Company

£70,659m

82 dealmakers

target

Array Biopharma

bidder

Pfizer

£9,049m

51 dealmakers

target

Allergan

bidder

Abbvie

£67,600m

99 dealmakers

target

OTEZLA

bidder

Amgen

£10,900m

45 dealmakers

target

SYNTHORX

bidder

Sanofi

£1,902m

50 dealmakers

target

Merck & Co (women’s Health, Trusted Legacy Brands, And Biosimilars Businesses)

bidder

Institutional Investors

£5,390m

17 dealmakers

target

GRAIL

bidder

Illumina

£6,190m

107 dealmakers

target

Alexion Pharmaceuticals

bidder

Astrazeneca

£29,441m

63 dealmakers

target

Amoun Pharmaceutical Company

bidder

Abu Dhabi Development Corporation (adq)

£538m

23 dealmakers

target

Ppd

bidder

Thermo Fisher Scientific

£15,220m

62 dealmakers

target

Aldevron

bidder

Danaher Corporation

£6,820m

52 dealmakers

target

Translate Bio

bidder

Sanofi

£2,302m

52 dealmakers

target

Bausch Health (eye Health Business)

bidder

Institutional Investors

value n/a

10 dealmakers

target

Prometheus Biosciences

bidder

Merck & Co

£8,698m

50 dealmakers

target

Ellab

bidder

Novo Holdings

value n/a

7 dealmakers

target

Abcam

bidder

Danaher Corporation

£4,530m

41 dealmakers

target

Mirati Therapeutics

bidder

Bristol Myers Squibb Company

£3,840m

54 dealmakers

target

IMMUNOGEN

bidder

Abbvie

£7,952m

33 dealmakers

target

Cerevel Therapeutics

bidder

Abbvie

£6,894m

53 dealmakers